Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 4 | +11.8K | 32.1% | $2.64 | +$31.2K |
Sells | 1 | -25K | 67.9% | $3.06 | -$76.5K |
Net | +3 | -13.2K | -35.9% | -$45.3K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
James C. Czirr | 10%+ Owner | $22.7M | -$76.5K | -0.34% | Apr 22, 2024 |
Richard E. Uihlein | Director, 10%+ Owner | $17.7M | Jan 24, 2024 | ||
10X Fund, L.P. | 10%+ Owner | $10.6M | Dec 31, 2022 | ||
Joel Lewis | President and CEO, Director | $3.15M | +$3.39K | +0.11% | Apr 24, 2024 |
Kevin D. Freeman | Director | $289K | +$13.4K | +4.86% | Jun 20, 2024 |
Kary Eldred | Director | $129K | +$2.81K | +2.22% | Jul 22, 2024 |
Richard A. Zordani Jr. | Director | $78.4K | +$11.6K | +17.3% | Aug 22, 2024 |
Pol F. Boudes | Chief Medical Officer | $71.4K | Jan 24, 2024 | ||
Jack W. Callicutt | Chief Financial Officer | $71.4K | Jan 24, 2024 | ||
Khurram Jamil | Chief Medical Officer | $23.9K | Aug 2, 2024 | ||
Marc Rubin | Director | Jan 24, 2024 | |||
Gilbert F. Amelio | Director | Jan 24, 2024 | |||
Gilbert S. Omenn | Director | Jan 24, 2024 | |||
Harold H. Shlevin | Director | Jan 26, 2023 | |||
Elissa J. Schwartz | Director | Jan 24, 2024 | |||
Benjamin Carson | Director | Jan 24, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|